Drugs / P-IFN alfa 2a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02112630 | May 2013 → Feb 2015 | chronic hepatitis C virus infection, end stage renal failure | Columbia University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P-IFN alfa 2a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02112630 ↗ |